debrisoquin and sulfamethazine

debrisoquin has been researched along with sulfamethazine in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19904 (25.00)18.7374
1990's10 (62.50)18.2507
2000's1 (6.25)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Henschel, L; Hoffmann, A1
Henschel, L; Hoffmann, A; Sigusch, H1
Barry, M; Feely, J; Holland, P1
Henschel, L; Hoffmann, A; Huster, A; Jorke, D; Kraul, H; Reinhardt, M; Töpfer, R; Truckenbrodt, J1
Jiang, WD; Xu, XM1
Heafield, MT; Steventon, GB; Sturman, S; Waring, RH; Williams, AC1
Idle, JR; Karakaya, AE; Sardaş, S1
Baumann, P; Bosshart, P; Gabris, G; Gastpar, M; Koeb, L; Woggon, B1
Acharya, VN; Kshirsagar, NA; Pohujani, SM; Satoskar, RS; Takle, MR1
Boutagy, J; Peart, GF; Shenfield, GM1
Baumgarten, R; Eike, E; Eike, O; Fengler, JD; Franke, G; Siegmund, W; Zschiesche, M1
Harland, CC; Marsden, JR; Steventon, GB1
Hoffmann, A; Lautenschlager, MT; Müller, UA; Viktor, S1
Gawrońska-Szklarz, B; Górnik, W; Kunicki, P; Pawlik, A; Sitkiewicz, D; Sych, Z; Wójcicki, J1

Trials

1 trial(s) available for debrisoquin and sulfamethazine

ArticleYear
[Comparison of serum concentrations of caffeine, 4-methylaminoantipyrine, sulfamethazine and debrisoquin following oral administration of these substances as a cocktail in type II diabetics before and after insulin therapy].
    Die Pharmazie, 1996, Volume: 51, Issue:10

    Topics: Adult; Aged; Anti-Infective Agents; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 Enzyme System; Debrisoquin; Diabetes Mellitus, Type 2; Dipyrone; Drug Combinations; Female; Humans; Hypoglycemic Agents; Insulin; Isoenzymes; Male; Middle Aged; Pyrazolones; Sulfamethazine; Sympatholytics

1996

Other Studies

15 other study(ies) available for debrisoquin and sulfamethazine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
[Assessment of biotransformation capacity following oral administration of various model substances as cocktail].
    Zeitschrift fur Gastroenterologie, 1991, Volume: 29, Issue:12

    Topics: Acetylation; Administration, Oral; Adult; Biotransformation; Caffeine; Cytochrome P-450 Enzyme System; Debrisoquin; Dipyrone; Humans; Hydroxylation; Liver; Male; Phenotype; Sulfamethazine

1991
[The effects of verapamil and nifedipine on the biotransformation of model substances and on the indocyanine green elimination].
    Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR, 1991, Volume: 51, Issue:1

    Topics: Adult; Biotransformation; Caffeine; Debrisoquin; Dipyrone; Humans; Indocyanine Green; Liver; Liver Circulation; Male; Nifedipine; Sulfamethazine; Verapamil

1991
Pharmacogenetics and drug metabolism: an Irish perspective.
    Irish journal of medical science, 1991, Volume: 160, Issue:2

    Topics: Acetylation; Adult; China; Debrisoquin; Humans; Ireland; Metabolism; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Sulfamethazine

1991
[Simultaneous administration of various model substances for characterizing in vivo biotransformation in chronic liver diseases].
    Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR, 1990, Volume: 50, Issue:4

    Topics: Biotransformation; Caffeine; Debrisoquin; Dipyrone; Fatty Liver, Alcoholic; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Liver Function Tests; Male; Metabolic Clearance Rate; Sulfamethazine

1990
Debrisoquine hydroxylation and sulfamethazine acetylation in a Chinese population.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1990, Volume: 11, Issue:5

    Topics: Acetylation; Adolescent; Adult; Asian People; China; Chromatography, High Pressure Liquid; Debrisoquin; Female; Humans; Hydroxylation; Male; Phenotype; Sulfamethazine

1990
Xenobiotic metabolism in Alzheimer's disease.
    Neurology, 1990, Volume: 40, Issue:7

    Topics: Acetaminophen; Adolescent; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Carbocysteine; Debrisoquin; Female; Humans; Male; Methyltransferases; Middle Aged; Sulfamethazine; Xenobiotics

1990
Are the traits for drug acetylation and oxidation co-inherited?
    Clinical genetics, 1988, Volume: 34, Issue:2

    Topics: Acetylation; Adult; Debrisoquin; Female; Genes, Recessive; Humans; Isoquinolines; Male; Middle Aged; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Sulfamethazine

1988
Acetylation of maprotiline and desmethylmaprotiline in depressive patients phenotyped with sulfamidine, debrisoquine, and mephenytoin.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:2

    Topics: Acetylation; Anthracenes; Debrisoquin; Depressive Disorder; Gas Chromatography-Mass Spectrometry; Humans; Maprotiline; Mephenytoin; Phenotype; Sulfamethazine

1988
Sulphadimidine acetylation status in Gujarati and Marathi population.
    Journal of postgraduate medicine, 1987, Volume: 33, Issue:3

    Topics: Acetylation; Adult; Debrisoquin; Female; Gene Frequency; Humans; India; Male; Middle Aged; Phenotype; Sulfamethazine

1987
Debrisoquine oxidation in an Australian population.
    British journal of clinical pharmacology, 1986, Volume: 21, Issue:5

    Topics: Acetylation; Adolescent; Adult; Australia; Debrisoquin; Female; Genetic Variation; Humans; Isoquinolines; Male; Middle Aged; Oxidation-Reduction; Phenotype; Sulfamethazine; Urine; White People

1986
[Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)].
    Zeitschrift fur Gastroenterologie, 1993, Volume: 31 Suppl 2

    Topics: Acetylation; Arylamine N-Acetyltransferase; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Gilbert Disease; Humans; Hydroxylation; Metabolic Clearance Rate; Mixed Function Oxygenases; Phenotype; Polymorphism, Genetic; Sulfamethazine

1993
Thalidomide-induced neuropathy and genetic differences in drug metabolism.
    European journal of clinical pharmacology, 1995, Volume: 49, Issue:1-2

    Topics: Acetylation; Adrenergic Agents; Adult; Anti-Infective Agents; Debrisoquin; Dermatologic Agents; Female; Humans; Male; Neural Conduction; Peripheral Nervous System Diseases; Sulfamethazine; Thalidomide

1995
N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances.
    European journal of clinical pharmacology, 1997, Volume: 51, Issue:6

    Topics: Acetylation; Adult; Aged; Debrisoquin; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gene Frequency; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Sulfamethazine

1997